Clinical Trial Update: Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at UCSF is evaluating hyperpolarized pyruvate (13C) MR imaging to monitor prostate cancer in men under active surveillance. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Adenocarcinoma, Prostate Cancer | Phase 2 | Status: RECRUITING